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Abstract
Background: Ambitious UN goals to reduce the mother-to-child transmission of HIV have not been met in much
of Sub-Saharan Africa. This paper focuses on the quality of information provision and counseling and disclosure
patterns in Burkina Faso, Kenya, Malawi and Uganda to identify how services can be improved to enable better
PMTCT outcomes.
Methods: Our mixed-methods study draws on data obtained through: (1) the MATCH (Multi-country African
Testing and Counseling for HIV) study’s main survey, conducted in 2008-09 among clients (N = 408) and providers
at health facilities offering HIV Testing and Counseling (HTC) services; 2) semi-structured interviews with a sub-set
of 63 HIV-positive women on their experiences of stigma, disclosure, post-test counseling and access to follow-up
psycho-social support; (3) in-depth interviews with key informants and PMTCT healthcare workers; and (4)
document study of national PMTCT policies and guidelines. We quantitatively examined differences in the quality
of counseling by country and by HIV status using Fisher’s exact tests.
Results: The majority of pregnant women attending antenatal care (80-90%) report that they were explained the
meaning of the tests, explained how HIV can be transmitted, given advice on prevention, encouraged to refer their
partners for testing, and given time to ask questions. Our qualitative findings reveal that some women found
testing regimes to be coercive, while disclosure remains highly problematic. 79% of HIV-positive pregnant women
reported that they generally keep their status secret; only 37% had disclosed to their husband.
Conclusion: To achieve better PMTCT outcomes, the strategy of testing women in antenatal care (perceived as an
exclusively female domain) when they are already pregnant needs to be rethought. When scaling up HIV testing
programs, it is particularly important that issues of partner disclosure are taken seriously.
Keywords: PMTCT, Africa, HIV testing, Counseling, Consent, Disclosure
Background
The 2001 Special Session of the UN General Assembly
committed its 189 member states to provide 80% of preg-
nant women worldwide with access to Prevention of
Mother to Child Transmission of HIV (PMTCT) care by
2010. The aim was to reduce the proportion of infected
children born to HIV-positive mothers by 20% by 2005,
and then by a further 50% by 2010. These ambitious
goals have not been met by the majority of countries in
Sub-Saharan Africa. When the UN reviewed its progress
in 2010, it was estimated that only 53% of pregnant
women living with HIV in Sub-Saharan Africa had
received antiretroviral drugs to prevent mother-to-child
transmission [1]. Such findings led to a renewed UN
commitment to ensure that “pregnant women have
access to antenatal care, information, counseling and
other HIV services” [2]. This paper analyzes qualitative
and quantitative reports from PMTCT clients to assess
the quality of information provision and counseling for
PMTCT in Burkina Faso, Kenya, Malawi and Uganda,
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improved to enable better PMTCT outcomes.
PMTCT was first proposed as a global health policy in
the late 1990s [3,4]. Initially, WHO and UNAIDS recom-
mended a three-pillar strategy: to prevent (1) new infec-
tions among parents; (2) unwanted pregnancies among
HIV-infected women; and (3) transmission from HIV-
infected pregnant women and mothers to children [5]. In
2002, a WHO meeting proposed the inclusion of a fourth
pillar: to provide care and support to mothers, their infants
and their families [5]. These aims were endorsed at the
PMTCT High Level Global Partners Forum in Abuja,
N i g e r i ai n2 0 0 5[ 6 ] ,b yw h i c ht i m eg l o b a lp r e s s u r eh a d
made antiretroviral treatment available in resource-poor
settings.
That PMTCT would not be easy to implement became
clear in 2002 when UNICEF conducted pilot studies in
11 countries [7]. In these studies, an average of 30% of
women who visited antenatal care (ANC) sites were not
informed about PMTCT. Of those women who did
receive information about PMTCT, 30% did not receive
an HIV test. Findings from Kenya and Zambia revealed
that one-quarter of tested women did not return for their
results. Just over half of the women who tested positive
never received prophylactic antiretroviral treatment [7].
These studies were conducted before anti-retroviral
treatment became widely available–when being diag-
nosed with HIV was still equivalent to social ostracism
and death in most resource-poor settings.
HIV testing practices have changed dramatically since
the advent of large-scale antiretroviral treatment (ART)
programs, with provider-initiated HIV testing and coun-
seling programs now commencing many more people on
treatment [8]. In the early years of PMTCT in Africa,
testing was primarily a tool to prevent transmission to
children; in the era of ART scale-up, HIV tests have
become gateways to treatment for HIV-positive pregnant
women. Testing technologies have also changed. When
the UNICEF pilot studies were conducted, PMTCT test-
ing facilities would take blood from patients and send it
to laboratories for diagnosis; patients had to return for
their results, which partly explained the high dropout
rates. Nowadays, nearly all health facilities use rapid test-
ing kits requiring only a finger prick; 30 min later the
results are known.
The scaling up of testing and treatment has been accom-
panied by ethical debates on how best to prepare pregnant
women for HIV testing. Some argue that pre-test counsel-
ing should be comprehensive–to help clients consciously
choose for testing, to prepare for a potential positive out-
come, and to disclose and commit to prevention should
they be HIV-positive [9]. Proponents of comprehensive
counseling fear that routine testing approaches can harm
HIV-positive women by exposing them to severe stigma
and discrimination, for which they are not prepared.
Others suggest that as treatment is now available, HIV
tests have become ordinary diagnostic tools, though facil-
ities need to ensure that people feel the freedom to opt
out [10,11].
Recent studies in Africa report very high rates of con-
sent for HIV testing within PMTCT programs [12-17].
However, attrition in follow-up continues to be a serious
problem [14,18-21]. For example, Manzi et al. found that
while 95% of pregnant women attending antenatal care
in Malawi tested for HIV, only 45% of HIV-positive preg-
nant women and 34% of babies born to HIV-positive
mothers received ARV prophylaxis [14]. Similarly, Couli-
baly et al. found that only 36% of 1,829 HIV-positive
pregnant women in a PMTCT program in Abidjan, Côte
d’Ivoire received AZT [20].
Why are so few HIV-positive pregnant women and
their infants receiving ARVs? A qualitative study in
Malawi unveiled a variety of institutional and cultural
factors behind the low uptake of PMTCT: women unpre-
pared for HIV testing and its implications before visiting
the antenatal clinic; fear of stigma, discrimination, house-
hold conflict and divorce upon disclosure of HIV status;
husbands opposed to testing; long waiting times at
antenatal clinics; and high transportation costs for fol-
low-up visits [19]. Painter et al. (2004) found underlying
mistrust in health facilities and disbelief in test results to
be contributing to the low uptake of prophylactic drugs
in an antenatal clinic in Abidjan, Côte d’Ivoire [22]. In
Kenya, Delva et al. have pointed to the low quality of
PMTCT counseling, with crucial topics such as partner
involvement and follow-up support covered haphazardly
[23]. Creek et al. observed that post-testing counseling in
Botswana evaluated pregnant women for ARV therapy
but neglected their psycho-social needs [24].
In this paper, we use qualitative and quantitative data
to assess (1) the quality of counseling provided to
PMTCT clients, (2) how PMTCT clients perceive their
freedom to consent to testing, and (3) the challenges
they face in disclosing their status to others. We give an
overview of national-level PMTCT policy guidelines,
and suggest ways in which care provision can be
improved.
Methods
This paper’s findings are derived from the MATCH
(Multi-country African Testing and Counseling for HIV)
study, the first designed to systematically compare client
experiences with HIV testing across countries and modes
of testing. Numerous government and donor-supported
initiatives have been implemented in Burkina Faso,
Kenya, Malawi and Uganda, where HIV testing is increas-
ingly conducted within health facilities. The four coun-
tries face similar challenges in expanding their testing
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age of adequately trained staff, and difficulties with refer-
ral and follow-up. But there are differences in pace of
increase (somewhat slower in Burkina Faso) and in the
scale of resources invested (larger in Kenya and Uganda).
The MATCH study included a main survey conducted
in 2008-09 among clients and providers at health facilities
offering HTC services. The study was conducted in the
capital region and one rural province or district in each
country, where research teams purposefully selected the
facilities to include a variety of types of health facilities.
Research teams contacted those in charge at each facility,
obtained clearance, and asked them to inform clients
about the project. Interviews were planned on at least two
different days of the week, with an aim of interviewing a
total of 15 clients per facility. On the appointed days,
interviewers approached clients, described the study, and
invited them to participate. The fraction of respondents to
be interviewed at each of the selected facilities was based
on the expected numbers of respondents per day: at smal-
ler facilities all clients were invited to participate, whereas
at busier facilities, every n
th client was. The teams had to
adjust plans when attendance was low, or when health
staff did not present at the clinic. While the full MATCH
study includes both women and men, and respondents
who have and have not tested for HIV, the current paper
reports on the MATCH study’s findings as they pertain to
the subset of women who tested in an antenatal care facil-
ity or because of pregnancy.
The MATCH survey was administered in each country
by a team of experienced researchers, who were responsi-
ble for training field interviewers and data entry staff, and
have provided input into the survey design and interpreta-
tion of results. Prior to beginning the interview, respon-
dents were told about the study and asked to provide
consent. In most cases, written consent or a thumbprint
was given by respondents; however, in a few situations
where these methods of obtaining consent were deemed
unacceptable by the country team, verbal consent was
allowed. Field interviewers were project staff, and were not
associated with the health facilities where the interviews
were conducted. The interviews were conducted in French
(Burkina Faso), English (Kenya, Malawi, Uganda) or local
languages. The survey questionnaire included closed and
open-ended questions and usually lasted from around 30
min to 1 h. Data were collected on respondents’ socio-
demographic characteristics and their experiences with
HIV testing and counseling, using a checklist of interac-
tions and services during pre- and post-test meetings and
during follow-up care. Before entering the data into the
database, all questionnaires were checked for consistency.
In this paper we describe the experiences of HIV-posi-
tive and HIV-negative pregnant women who were tested
for HIV. The full MATCH client sample is comprised of
3,660 respondents. Of these, 2,117 respondents were
tested for HIV in or after 2007. Out if this sub-set, 421
respondents were PMTCT testers. Women were categor-
ized as PMTCT testers if they either reported testing in an
antenatal care facility or cited pregnancy or PMTCT as
their reason for testing in an integrated testing and medi-
cal facility, such as a hospital or general health clinic. We
excluded 13 PMTCT testers with missing HIV status from
the analysis. The final sample therefore included 408
women. These women were generally young (in their 20 s
and 30 s) with no or only primary education. In Burkina
Faso, educational level of the women was lowest: 40.4% of
the respondents had no formal education (see Table 1).
Two kinds of data were collected from this sub-set of
408 women: multiple choice responses to assess their
views and experiences of HIV testing, and answers to
open-ended questions which gave women an opportunity
to expand on their views and experiences of counseling,
consent and confidentiality (the 3Cs).
We used guidelines on HIV testing from major interna-
tional, United States, and European organizations [25-29]
to select variables to measure women’s views and experi-
ences of the 3Cs. In light of the debate over the extent of
necessary pre-test counseling, and the need to tailor post-
test counseling to test results [25,26,30], we examined pre-
and post-test counseling separately (see Table 2). In addi-
tion, the survey included measures for self-stigma, enacted
and community stigma from the WHO’sm a n u a lHIV
Testing, Treatment and Prevention: Generic Tools for
Operational Research [31], see Table 3. We used Stata
10.1 SE to conduct a descriptive analysis of the 3Cs and
measured significance of differences by country and by
HIV status using Fisher’s exact tests appropriate for the
relatively small sample size with a threshold for signifi-
cance at p =0 . 0 5 .
We closely examined experiences of stigma, disclosure,
post-test counseling and access to follow-up psycho-social
support in a sub-set of 63 HIV-positive women (6 in Bur-
kina Faso, 8 in Kenya, 34 in Malawi and 15 in Uganda),
using primarily their responses to the open-ended ques-
tion. And, to gain further insight into these issues, we held
14 in-depth interviews with key informants recruited
through support groups for HIV-positive individuals and
21 interviews with healthcare workers in PMTCT facilities.
To further probe on the experiences of HIV-positive indi-
viduals, the teams conducted 20 focus group discussions
with members of support groups (7 in Burkina Faso, 6 in
Kenya, 5 in Malawi, and 2 in Uganda). The focus group
discussions were facilitated by an experienced qualitative
researcher. All interviews except the key informant inter-
views with HIV-positive women attending support groups
and the focus group discussions were held in antenatal
care facilities. The interviews and focus group discussions
were transcribed and analyzed using NVivo 8 software.
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tries through document study and key informant inter-
views to determine the guidance given to health workers
on how to conduct counseling, and how to confront the
challenges of consent, confidentiality and disclosure in
pre- and post-test counseling.
The mixed-methods approach of this study allows us to
present quantitative measurements as well as qualitative
insights on the quality of counseling, consent and confi-
dentiality, and the stigma and disclosure challenges faced
by HIV-positive pregnant women. The study was not
designed to provide a representative picture of PMTCT
implementation in Burkina Faso, Kenya, Malawi and
Uganda. It rather aimed to describe policies and practice
as experienced by women in antenatal sites and to high-
light the issues at stake in further scaling up and increas-
ing access to PMTCT.
The study was reviewed by the ethics committees of
the Amsterdam Medical Center of the University of
Amsterdam, the World Health Organization, and rele-
vant bodies in each of the four African countries.
Results
PMTCT testing policies
The turn towards routine provider-initiated testing has
been accompanied by revision of national HIV testing and
counseling policies. At the time of our study, all four
countries emphasized the principle of informed consent.
For example, the 2005 Ugandan policy states that “All
HIV testing should be done with the client’sk n o w l e d g e
and consent” [32], while the 2008 Kenyan guidelines stress
that “No person shall be tested without their consent”
[33]. But national policies differ on the role and time
allotted to pre-test counseling. The Ugandan policy states
Table 1 Age, educational attainment, household assets, marital status, and number of previous HIV tests by country,
PMTCT testers
Burkina Faso Kenya Malawi Uganda Total
No. Col% No. Col% No. Col% No. Col% No. Col%
Age
18-25 years 46 44,2 21 28,8 65 47,4 46 50 178 43,8
25-34 years 55 52,9 44 60,3 59 43,1 40 43,5 198 48,8
35-44 years 3 2,9 7 9,6 12 8,8 6 6,5 28 6,9
45 years and more 0 0 1 1,4 1 0,7 0 0 2 0,5
Education
No formal education 42 40,4 0 0 23 16,7 8 8,7 73 17,9
Primary incomplete/complete 36 34,6 31 41,9 92 66,7 43 46,7 202 49,5
Secondary or more 26 25 43 58,1 23 16,7 41 44,6 133 32,6
Electricity
No 68 65,4 24 32,4 131 94,9 46 50 269 65,9
Yes 36 34,6 50 67,6 7 5,1 46 50 139 34,1
Plumbing
No 73 70,2 30 40,5 107 77,5 70 76,1 280 68,6
Yes 31 29,8 44 59,5 31 22,5 22 23,9 128 31,4
Flush toilet
No 102 98,1 42 56,8 132 95,7 87 94,6 363 89
Yes 2 1,9 32 43,2 6 4,3 5 5,4 45 11
Marital status
never married 6 5,8 10 13,5 3 2,2 12 13 31 7,6
married or cohabiting 94 90,4 64 86,5 123 89,1 78 84,8 359 88
divorced/separated 3 2,9 0 0 8 5,8 1 1,1 12 2,9
Widowed 1 1 0 0 4 2,9 1 1,1 6 1,5
Number of times tested
1 57 54,8 35 47,3 66 47,8 34 37 192 47,1
2 32 30,8 26 35,1 43 31,2 24 26,1 125 30,6
3 or more 15 14,4 13 17,6 29 21 34 37 91 22,3
Total 104 100 74 100 138 100 92 100 408 100
Hardon et al. BMC Public Health 2012, 12:26
http://www.biomedcentral.com/1471-2458/12/26
Page 4 of 15that counseling should be “comprehensive” unless the
extra time required “causes a barrier to testing itself” [32].
In contrast, the 2008 Kenyan policy places less emphasis
on pre-test counseling, implying a form of triage practiced
post-test, with those found to be HIV-positive entitled to
comprehensive post-test counseling. The Malawian and
Burkina Faso policies require pre-test counselors to inform
w o m e nt h a tt h e yh a v et h eright to opt out of testing
[34,35]. Burkina Faso’s national HIV Counseling and Test-
ing (HCT) policy adds that counselors must respect client
“autonomy” and understand their reasons for refusing; it
recommends improved counseling for more women to
accept testing [35].
National policies also differ on confidentiality and dis-
closure. The 2008 Kenyan HTC policy states that client
information cannot be shared without their consent. But
the policy–citing evidence that switching from anon-
ymous to confidential HTC does not negatively affect the
uptake of HTC services [33]–also states that names
rather than codes can now be used in client records to
facilitate referral. In contrast, Burkina Faso’s policy stres-
ses that test results cannot be shared with third parties,
including colleagues, without the client’s consent, and
that the “principle of autonomy” demands that the cli-
ent’s name be replaced with a code [35]. Uganda’s 2005
HCT policy is brief on the issue of confidentiality, stating
that “HIV test results and patient records should be kept
in a locked file with access limited to HCT personnel”
[32]. It further states that the HCT site should not dis-
close results to anyone without the client’s written con-
sent, except when “a court requires it” [32]. Uganda’s
2006 PMTCT policy does not mention confidentiality
[36]. Malawi’s 2008 PMTCT policy also has little to say
about confidentiality; it espouses a couple- and family-
centered model where health workers encourage shared
confidentiality and disclosure among couples [37].
In Kenya and Burkina Faso, legislation–based on a tem-
plate drafted by parliamentarians from 12 African coun-
tries to protect the rights of individuals infected or
exposed to HIV [38]–has been passed requiring HIV-posi-
tive individuals to disclose to sexual partners. The 2008
Kenyan HTC policy is the most forceful on this point, stat-
ing that HTC workers should support their clients to dis-
close to sexual partners and that “if efforts to encourage
the client or patient to disclose their HIV status fail, and
Table 2 The 3C’s variables used in our study
Pre-test counseling
Met with counselor before the test
Provider explained how HIV is transmitted
Provider explained the meaning of HIV-positive and negative
results
Given time to ask questions
Post-test counseling
Received the results
Provider explained the meaning of the results
Provider gave advice on prevention
Provider suggested to discuss status with someone
Provider advised partner referral
Provider gave time to ask questions
Consent
Provider asked if respondent agreed to test
Provider explained that respondent had a choice to accept or
refuse
Confidentiality
Provider explained that results would not be shared
Respondent believes results have been protected
Satisfaction with post-test counseling
Received sufficient information
Was well treated
Thought meeting was useful
Referral index (HIV positives only)
Referred for care
Referred to a support group
Prescribed medications
Table 3 Stigma variables
Self-stigma
“I sometimes feel worthless because I am HIV-positive”
“I feel guilty because I have HIV”
Enacted stigma
“Have you personally ever been made to feel bad because of things people did or say to you on account of your HIV status?”
“Did health workers ignore or avoid caring for you?”
Reported community stigma
“Have you heard of people who have been badly treated because they have HIV?”
Attitudes and behaviors related to disclosure
“Important that nobody knows results”
“Kept status secret”
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person at risk, a medical practitioner may disclose some-
one’s HIV status to their sexual partner or other person at
risk” [33]. Refusal to notify one’s partner is thus consid-
ered an infringement of the partner’s right to health and
well-being. Burkina Faso’s 2008 HCT policy refers to law
N° 030-2008/AN (Article 7), which states that “any person
living with HIV is required to promptly disclose their HIV
status to their spouse or sexual partner” [35]. But unlike in
Kenya, Burkina Faso’s policy emphasizes that health work-
ers cannot reveal clients’ HIV status without their written
consent; it encourages health workers to be “patient and
understanding with respect to the positive partner who is
reluctant to reveal their HIV status to their partner at
first” [35].
Women’s views on HIV testing
To explore views on HIV testing, we asked women
whether it was hard to be tested. Most (84%) said that it
was not. When asked why, their responses reflected prior
experience with testing and confidence in a likely HIV-
negative result due to their awareness of HIV transmis-
sion routes. A 26 year old, HIV-negative married woman
from urban Kenya said: “I had been faithful to my hus-
band since testing negative in 2002.” It was the same
s t o r yf o ray o u n g ,H I V - n e g a t i v em a r r i e dw o m a nf r o m
rural Uganda, tested in a government hospital: “Because I
had done it before and am also faithful to my husband.”
A 34 year old, HIV-negative married woman from rural
Malawi: “Because I was thoroughly advised to be faithful,
which I have been practicing, hence I had no fear.”
Some client-respondents said that it was important for
the woman to have “made up her mind” before the test. A
young educated woman in urban Uganda who refused to
be tested stated: “I felt I was not ready for the test that
day.” As HIV testing is now a common healthcare practice
in all four countries, the offering of the test in antenatal
care did not come as a surprise to our informants. In fact,
53% of our respondents had been tested more than once
(see Table 1). 40% of pregnant women in Malawi, 34% in
Kenya, 29% in Uganda and 18% in Burkina Faso had dis-
cussed having an HIV test with someone before coming to
the clinic. In nearly all such cases, they talked to their hus-
bands or partners. In Malawi, some women indicated that
their husbands had “encouraged” them to be tested.
The qualitative findings suggest high levels of satisfac-
tion with PMTCT. The services are valued because they
help protect the health of the unborn child and because
they provide a gateway to treatment. A young HIV-nega-
tive woman tested in a government hospital in rural Kenya
for example asserted: “It is good... because I was pregnant
and wanted to know my status and it is also a must for
pregnant mothers.” Another young woman tested in a
government hospital in rural Uganda added: “It is good
because if a mother is found positive she is always given
treatment.”
Two out of three HIV-positive women said they were
glad to know their status and that good things happened
to them since learning of their status. They gave various
reasons for this. One woman reported that she had learnt
to live positively and was able to prevent transmission to
her child; another said that her health had improved and
that she was still together with her husband. Another
woman stated: “I started taking ARVs and I am healthy
and nobody can suspect I am positive.”
Experiences with pre and post-test counseling
In all four countries nearly all women (regardless of status)
reported that they were treated well and that the PMTCT
meeting was helpful overall (see Table 4). The rates for
the 3Cs variables (for the total sample) were above 80%,
with the exception of two variables: ‘time to ask questions
post-test’ (78% of women were satisfied) and ‘advised to
discuss their status with others’ (69% of women reported
that they were advised to disclose).
The statistical analysis reveals that there are no signifi-
cant differences between the countries for the variables
‘met with a counselor’, ‘explained how HIV is transmitted’,
‘counselor asked if you agreed to be tested’, ‘received
results’ and ‘explained meaning of results’.H o w e v e r ,s t a t i s -
tically significant differences between the countries were
observed for ‘pre-test: explained the meaning of HIV posi-
tive or negative results’, ‘time to ask questions’, ‘explained
that results will not be shared’, and for advice on preven-
tion, partner referral and disclosure. In Burkina Faso,
scores appear to be particularly low on these ‘comprehen-
siveness’ variables: only 55% of respondents reported that
during pre-test counseling the meaning of results was
explained to them; only 67% said they were given time to
ask questions pre-test; during post-test even fewer women
were given a chance to ask questions (55%); only 69%
were given advice on prevention and only 27% of respon-
dents were advised to discuss their status with others. Bur-
kina Faso also has the lowest number of respondents who
report that they are satisfied with the information received
in PMTCT (77% versus 95% in Kenya and 94% Uganda
and 83% in Malawi). A high proportion of our respondents
in Burkina have a low educational status (see Table 1),
which could explain the lower reported quality of counsel-
ing in the country. Perhaps the health workers explain less
because they do not expect that their clients will under-
stand the information provided.
We expected that the HIV-positive women would eval-
uate the services more negatively: they require compre-
hensive counseling and may have many questions, while
health workers are generally pressed for time. But this
was not the case. Significantly higher percentages of
HIV-positive women reported being given time to ask
Hardon et al. BMC Public Health 2012, 12:26
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Burkina Faso Kenya Malawi Uganda Total P value*
No. Col% No. Col% No. Col% No. Col% No. Col%
Pre-test: meet with counselor before test
No 3 2,88 5 6,76 11 8,03 9 9,78 28 6,88 0,220
Yes 101 97,12 69 93,24 126 91,97 83 90,22 379 93,12
Pre-test: explain how HIV is transmitted
No 8 7,92 4 5,8 5 3,97 6 7,23 23 6,07 0,604
Yes 93 92,08 65 94,2 121 96,03 77 92,77 356 93,93
Pre-test: explain the meaning of positive and negative results
No 46 45,54 5 7,25 8 6,35 4 4,82 63 16,62 0,000
Yes 55 54,46 64 92,75 118 93,65 79 95,18 316 83,38
Pre-test: give time to ask questions in pre-test counseling
No 33 32,67 7 10,14 8 6,35 15 18,07 63 16,62 0,000
Yes 68 67,33 62 89,86 118 93,65 68 81,93 316 83,38
Found it difficult to test
No 79 79 55 79,71 113 91,13 70 84,34 317 84,31 0,044
Yes 21 21 14 20,29 11 8,87 13 15,66 59 15,69
Consent: ask if you agreed to test
No 6 5,94 4 5,8 10 7,94 11 13,41 31 8,2 0,282
Yes 95 94,06 65 94,2 116 92,06 71 86,59 347 91,8
Consent: explain that you had a choice to agree or refuse
No 15 14,85 6 8,7 14 11,11 26 31,71 61 16,14 0,000
Yes 86 85,15 63 91,3 112 88,89 56 68,29 317 83,86
Confidentiality: explain that results will not be shared
No 27 27 8 11,59 4 3,17 4 4,82 43 11,38
Yes 73 73 61 88,41 122 96,83 79 95,18 335 88,62 0,000
Confidentiality: believe that results have been protected
No 16 15,38 12 16,22 9 6,67 24 26,97 61 15,17 0,001
Yes 88 84,62 62 83,78 126 93,33 65 73,03 341 84,83
Post-test: received results
No 0 0 0 0 1 0,73 2 2,2 3 0,74 0,348
Yes 104 100 74 100 136 99,27 89 97,8 403 99,26
Post-test: information is sufficient
No 24 23,08 4 5,41 8 5,88 15 16,85 51 12,66 0,000
Yes 80 76,92 70 94,59 128 94,12 74 83,15 352 87,34
Post-test: Explain meaning of result
No 3 2,88 5 6,85 2 1,48 4 4,49 14 3,49 0,202
Yes 101 97,12 68 93,15 133 98,52 85 95,51 387 96,51
Post-test: give advice on prevention
No 32 30,77 9 12,33 5 3,7 7 7,87 53 13,22 0,000
Yes 72 69,23 64 87,67 130 96,3 82 92,13 348 86,78
Post-test: advise to discuss status
No 76 73,08 11 15,07 21 15,56 18 20,22 126 31,42 0,000
Yes 28 26,92 62 84,93 114 84,44 71 79,78 275 68,58
Post-test: advise partner referral
No 28 26,92 11 15,07 8 5,93 7 7,87 54 13,47 0,000
Yes 76 73,08 62 84,93 127 94,07 82 92,13 347 86,53
Post-test: time to ask questions
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Page 7 of 15questions, advised to discuss their status and advised to
refer their partners. (see Table 5). Most of the HIV posi-
tive women were prescribed HIV medication (85%), and
around two-thirds were referred to a support group (see
Table 6).
A closer look at experiences with consent
Does the scaling up of testing come at the expense of
women knowing that they can opt out, as has been sug-
gested by some earlier studies [39]? In our study, 92% of
PMTCT testers reported being asked if they agreed to
Table 4 Measures of pre-test and post-test counseling, confidentiality, consent, and satisfaction, by country (Continued)
No 47 45,19 7 9,59 14 10,37 19 21,35 87 21,7 0,000
Yes 57 54,81 66 90,41 121 89,63 70 78,65 314 78,3
Satisfaction: post-test meeting was helpful overall
No 1 0,96 3 4,05 3 2,21 7 7,87 14 3,47 0,054
Yes 103 99,04 71 95,95 133 97,79 82 92,13 389 96,53
Satisfaction: treated well overall
No 0 0 6 8,11 3 2,21 26 29,55 35 8,73 0,000
Yes 103 100 68 91,89 133 97,79 62 70,45 366 91,27
*Fischer exact test
Table 5 Measures of post-test counseling, by HIV status
HIV-negative HIV-positive Total P-value*
N%N% N %
Post-test: received results
No 2 0.6 1 1.6 3 0.7 0.403
Yes 340 99.4 63 98.4 403 99.3
Post-test: meaning of result explained
No 13 3.8 2 3.2 15 3.7 1.000
Yes 326 96.2 61 96.8 387 96.3
Post-test: given advice on prevention
No 50 14.7 4 6.3 54 13.4 0.105
Yes 289 85.3 59 93.7 348 86.6
Post-test: advised to discuss status***
No 116 34.2 11 17.5 127 31.6 0.008
Yes 223 65.8 52 82.5 275 68.4
Post-test: advised to refer partner***
No 51 15 3 4.8 54 13.5 0.027
Yes 288 85 59 95.2 347 86.5
Post-test: time to ask questions***
No 84 24.8 4 6.3 88 21.9 0.001
Yes 255 75.2 59 93.7 314 78.1
Satisfaction: post-test information was sufficient
No 44 12.9 7 11.1 51 12.7 0.837
Yes 296 87.1 56 88.9 352 87.3
Satisfaction: post-test meeting was helpful overall
No 13 3.8 1 1.6 14 3.5 0.706
Yes 327 96.2 62 98.4 389 96.5
Satisfaction: treated well overall
No 30 8.9 5 7.9 35 8.7 1.000
Yes 308 91.1 58 92.1 366 91.3
*two-sided Fisher’s exact
**Denominator includes only respondents who indicated someone should be told
***significant difference between HIV-positive and HIV-negative respondents (p < 0.05)
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Page 8 of 15testing; 84% were informed that they had the right to
refuse. But women’s experiences varied. A focus group
discussion among women who had visited the Compre-
hensive Care Centre at a National Hospital in Kenya
revealed that they could, at least in theory, refuse the
HIV test: “You have a choice because you are not being
forced.”“ If you do not want to be tested you can
refuse.”“ There is no pressure to agree to be tested.” But
one respondent added: “T h ed o c t o ri sv e r yp o w e r f u l .I f
he tells you... you have to agree. If a doctor or any other
medical person tells you to get tested, you do not have
any other alternative but to get tested.”
Other women reported that testing was mandatory. A
married, 23 year old HIV-negative woman from rural
Kenya, tested in a government Health Center, reported:
“The nurse said it was mandatory when pregnant for
PMTCT.” A married, HIV-negative woman from urban
Malawi, tested in a government hospital, likewise reported:
“We were told that HIV testing and counseling is a must
for pregnant women these days: no HTC, no assistance
from the doctor.” It was the same for a young, uneducated,
HIV-negative woman from urban Uganda, tested in a gov-
ernment hospital: “It was mandatory and a prerequisite for
me to get treatment.” In Burkina Faso, some women who
refused the test were asked to sign a form, which was
experienced as intimidating.
Many of our respondents did not oppose mandatory
testing. When probed on who should be tested, pregnant
women were most commonly mentioned, while other
answers included unfaithful husbands and sex workers.
But other respondents stressed that forcing women to test
for HIV was not good. They reasoned that some indivi-
duals would not be able to handle the results that women
should be able to choose for themselves, and that manda-
tory testing would scare women away from antenatal care.
One rural uneducated woman in Malawi referred to a vio-
lation of rights: “It’s not good since if she is not ready, her
rights can be violated.”
Opting out by pregnant women burdens health work-
ers as they then have to keep track of the women and
keep offering tests. As a matron in charge of a maternity
in Kenya explained:
There are situations when antenatal mothers come and
we are supposed to capture them for testing in their
first visit, and when you give the information and coun-
sel them especially on matters related to HIV, some will
say, “look, sister, because I did not come with my hus-
band, I would prefer to take the test when we are
together.” You just release her but on a subsequent visit
she will repeat the same story about the husband not
consenting, and she won’t tell you she is declining. On
another visit she lands on someone else’s hands and
not you who had counseled her, and the same story is
repeated, not knowing that one had been counseled
earlier and she is refusing indirectly. Finally, you rea-
lize that the mother is approaching delivery and has
not been tested, like yesterday we had one, she kept on
refusing to take the test, one of the counselors called me
and narrated the story, we went to the mother and told
her to sign that she has refused to take the test.... When
we meet such clients we do continue counseling, we
never get tired until the client agrees or disagrees...
Some health workers revealed that they deal with the
challenge of “capturing” women by telling them that the
test is mandatory: “They accept once you explain to them
that the test is mandatory at ANC”, explained an ANC
counselor in a Kenyan health centre. An ANC nurse in a
Ugandan health center likewise stated: “We talk to them
about HIV testing, we tell them about the benefits, we
then tell them that it is a government policy for all preg-
nant mothers to test.”
Stigma and confidentiality
Most HIV-positive women (79%) reported that they gener-
ally kept their HIV status secret. When probed about
stigma, one out of five respondents reported that they felt
worthless due to being HIV-positive; an equal proportion
felt guilty. One out of four had been personally made to
feel bad, and around half had heard about other HIV-posi-
tive people being treated badly. Only one respondent
reported that health workers avoided caring for her (see
Table 7).
T h el a r g em a j o r i t y( 8 5 % )f e l tt h a tt h eh e a l t hw o r k e r s
and counselors respected their desire for confidentiality
by protecting their results (See Table 4). An example of
breached confidentiality was given by a 22 year old
woman from Malawi, who tested positive in a rural
health center when she was pregnant in 2008. A counse-
l o rf r o mas u p p o r tg r o u ph a dd i s c l o s e dh e rs t a t u st o
Table 6 Referral to care (HIV-positive PMTCT testers only)
HIV-positive
No. Col %
Referred for care
No 19 31,1
Yes 42 68,9
Prescribed medication for HIV
No 9 14,8
Yes 52 85,2
Referred to support group in post-test counseling
No 23 37,7
Yes 38 62,3
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Page 9 of 15others in the community without her consent: “The
counselor of publicized at my village that I’ve been found
positive, which has left many people to know though I
took it as confidential.”
Low levels of partner disclosure
In our study, 83% of the HIV-positive pregnant women
had disclosed to someone. Mostly they disclosed to
family members (63%), usually their sister and/or par-
ents. Only one in three had disclosed to their partners,
while one in ten had disclosed to a friend.
Given post-test counseling’se m p h a s i so nd i s c l o s i n gt o
partners, it was surprising that only one-third of the
HIV-positive pregnant women had done so. Analysis of
the open-ended questions revealed that some of these
women were divorced or widowed. But many others
reported that they found it very difficult to tell their hus-
bands, out of fear of being blamed, abused and/or aban-
doned. A 22 year old woman, tested in an urban Kenyan
health center and encouraged by health workers to dis-
close to her husband and convince him to test, stated:
“My spouse denied that I was positive and did not take
the test. He thought then and still thinks it’s a joke.” A2 9
year old pregnant woman, tested in a government hospi-
tal in rural Kenya who has known her HIV-positive status
for 16 months said she was afraid to disclose because she
expected her husband to beat her up and leave her. It
was a similar story for a 19 year old pregnant woman in
Uganda; she had learnt her HIV-positive status 3 months
prior to our interview and had not disclosed to anybody,
including her partner: “my husband would divorce me
even if he knows that he is infected.” Only a few of the
women that we interviewed in Uganda and Kenya were a
member of a support group at the time of our interview.
A 25 year old HIV-positive woman was encouraged by
health workers at an urban health center in Burkina Faso
to disclose to her parents. She disclosed to her parents as
well as to her brother and husband. Disclosing to her
h u s b a n dd i dn o tg os m o o t h l y :“I have had to fight with
my husband, he told me he had someone else, he would
chase me away because I have AIDS and he doesn’t. He
also told his friends and other relatives that I have
AIDS.” S h ej o i n e das u p p o r tg r o u p ,a sd i dt w oo ft h e
other six HIV-positive mothers in Burkina Faso.
We interviewed 34 women who tested HIV-positive in
Malawi, more than in any other country. Relatively many
(13 out of 34) had joined a support group. Eight of them
reported having disclosed to their partners. One 30 year
old woman described how her husband “chased me out
of our house for a week” when she disclosed to him. She
is not intending to disclose to anyone else because she
Table 7 Measures of stigma and disclosure (HIV-positive
PMTCT testers only)
N%
Disclosure
Important that nobody knows results
Very important 53 85.5
Somewhat important 4 6.5
Not important 5 8.1
Kept status secret
No 13 20.6
Yes 50 79.4
Told someone results
No 11 17.5
Yes 52 82.5
Told partner results*
No 32 62.7
Yes 19 37.3
Told family results*
No 19 37.3
Yes 32 62.7
Told friend results*
No 46 90.2
Yes 5 9.8
Stigma and discrimination
Self-Stigma:
feel worthless because HIV+
Undecided/disagree/strongly disagree 48 80
Strongly agree/agree 12 20
feel guilty because HIV+
Undecided/disagree/strongly disagree 47 81
Strongly agree/agree 11 19
Enacted stigma/discrimination:
personally been made to feel bad
No 44 74.6
Yes 15 25.4
health workers ignored or avoided caring for you
No 59 98.3
Yes 1 1.7
Reported community stigma:
heard of people who have been badly treated
No 31 51.7
Yes 29 48.3
Good things happened because status known
No 20 34.5
Yes 38 65.5
*Denominator is persons who’ve told someone their status
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Page 10 of 15doesn’t want to be laughed at. A 35 year old woman
reported: “my husband left me for another wife.” Another
woman was divorced after she disclosed. Staff at a rural
health center had suggested that she should disclose to
her mother and relatives; she feared that they wouldn’t
accept the results and decided to disclose to her husband
instead. He accused her, demanded to know how she got
infected, and subsequently left her. But in some cases,
the husband grew more accepting over time. One young
woman reported that her husband was at first angry and
accused her, but now treats her better. A 40 year old
woman, tested in an urban government hospital,
explained that she disclosed because “it was good to let
him know.” He is supportive now but gets worried when
she falls ill with, for example, malaria. She will not dis-
close to others because “people might start gossiping
whenever they know my status, as a result I will lack
peace of mind.”
The in-depth interviews revealed that disclosure is not
always direct. Some women disclosed by encouraging
their partners to go with them to couple’s counseling and
testing; others disclosed by not hiding their antiretroviral
drugs.
Discussion
This four-country study reveals that pregnant women
are generally satisfied with HTC in antenatal care. It is
valued because it helps protect the health of the unborn
child and because it provides a gateway to treatment.
Women generally reported that they did not find the
HIV test hard to take. Around half of our respondents
were repeat-testers and knew what to expect.
The results of our quantitative analysis reveal that over-
all the majority of pregnant women attending antenatal
care (80-90%) report that they were explained the mean-
ing of the tests, explained how HIV can be transmitted,
given advice on prevention, encouraged to refer their
partners for testing, and given time to ask questions. In
all four countries, nearly all women (regardless of their
HIV status) reported that they were treated well and that
the meeting was helpful overall.
The policy analysis shows that counselors in all coun-
tries are expected to ask for consent before conducting
an HIV test, but that there are differences in HTC policy
regarding the comprehensiveness of pre- and post-test
counseling and the requirements of confidentiality. The
statistical analysis reveals that there are no significant dif-
ferences between the countries for the 3Cs variables ‘met
with a counselor’, ‘explained how HIV is transmitted’,
‘counselor asked if you agreed to be tested’, ‘received
results’ and ‘post test: explained meaning of results’,
reflecting convergence in policy between the countries
on these ‘minimal’ elements of HTC. However statisti-
cally significant differences between countries were
observed for other 3Cs variables, including ‘pre-test:
explained meaning of results’, ‘time to ask questions’ and
advice on prevention, disclosure and partner referral.
These results reveal that the ‘comprehensiveness’ of the
HTC in ante-natal care services varies between the coun-
tries (and probably also by facility within the countries,
but because of sample size limitations we could not test
for this). Our findings suggest that the quality of counsel-
ing is lowest in Burkina Faso, where fully 46% of women
said that they were not explained the meaning of HIV
positive and HIV negative test results in pre-test counsel-
ing, while post-test 45% were not given a chance to ask
questions, 31% were not given advice on prevention, and
73% of respondents were not advised to discuss their sta-
tus with others. These findings may reflect relatively low
educational levels among respondents in Burkina Faso
and health workers assuming that uneducated women
will not understand the information they provide. An
earlier study on the quality of HIV testing and counseling
care in 14 Burkina Faso health facilities [40] reported
remarkably similar findings: 46% of clients were not
explained the significance of positive or negative test
results in pre-test counseling, and only 44% of clients
were not given a chance to ask questions. The limited
attention to disclosure in the counseling sessions in Bur-
kina Faso could be related to the emphasis in the Burkina
Faso policy on confidentiality. The Burkina Faso HCT
policy states that health workers need to be patient and
understanding when an HIV positive person does not
want to disclose.
While our quantitative assessment of consent showed
that pregnant women in all four countries have the
option to refuse the test, the qualitative findings suggest
that some women feel it is an “offer they cannot refuse.”
Different views prevail on mandatory testing for HIV. In
Uganda and Kenya, we found some providers–and some
women–supporting it for pregnant women; underlying
their stance is the moral imperative to protect the
unborn child. Many women in Malawi and Burkina
Faso, in line with these countries’ policies, asserted that
women should have the right to refuse HIV testing.
We found that healthcare workers in the four coun-
tries provided post-test counseling of a significantly
higher standard to HIV-positive women than to their
HIV-negative counterparts. Even so, 20% of the HIV-
positive women in our study reported that they felt
guilty or worthless, suggesting that self-stigma continues
despite increased access to anti-retroviral treatment in
all four countries.
Compared to other studies [41,42] we found relatively
high levels of disclosure: 83% of our HIV-positive
respondents had disclosed to someone, usually a family
member. But disclosure was selective. Women simulta-
neously told us that they generally kept their status
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ment, they continue to fear stigma and social suffering if
word about their HIV status spreads in the community.
As Bond [43] points out, women appear to juggle the
pragmatic advantages of disclosing to a limited circle of
people with the importance of maintaining their moral
integrity. Their underlying fear is to be blamed for being
promiscuous, or for introducing the virus into the
family. A recent cross-sectional study in rural Kenya
[44] found that 37% of pregnant women accepting an
HIV test feared that they would be rejected and/or phy-
sically abused by their partners if they tested positive
and their partners found out.
Only 37% of the HIV-positive women in our study
had disclosed to their partners, despite the emphasis on
partner disclosure in post-test counseling in all four
countries. Analysis of the qualitative data revealed that
disclosure can create serious rifts with partners; some
women were abandoned or divorced by their husbands.
These findings confirm those from earlier studies on the
influence of anticipated rejection and violence from boy-
friends and husbands on partner disclosure [45-50].
The risk of intimate partner violence is a crucial issue
that needs to be addressed in PMTCT programs. Our
findings suggest that enacted stigma is still prominent
among HIV-positive pregnant women in Sub-Saharan
Africa, despite the widespread availability of ART. Roura
et al. [49] point out that this is due to ART availability
only marginally affecting the discourse of blame that lies
behind enacted stigma (the authors argue that self-stigma
has declined). Women who test positive in PMTCT gen-
erally find out when they are not yet ill–earlier than their
male sexual partners who tend to be tested when a health
worker suggests a diagnosticH I Vt e s t .M a n yH I V - p o s i -
tive pregnant women thus fear being blamed for introdu-
cing the infection into the family. A study in rural
Malawi found that some women waited until their hus-
band showed signs of illness before disclosing their posi-
tive status [51].
While our survey found healthcare workers to be sys-
tematically advising pregnant women to refer their hus-
bands for testing, the in-depth interviews revealed that
partners rarely come in for testing. This may be due to
men’s reluctance to be seen in antenatal clinics, which
are seen as part of a ‘female’ domain; attending one
would risk questions from peers about one’sm a s c u l i n i t y
[52]. In countries such as Burkina Faso and Kenya where
HIV transmission is criminalized, HIV-positive pregnant
women could theoretically even be prosecuted for infect-
ing their husbands and children. The potential adverse
effects of disclosure for women, particularly during the
socially vulnerable period of pregnancy, suggest a need
for accompanying measures that promote early testing
among men. This is further supported by the findings
that men tend to more often disclose to their partners
than women [53], and that knowing one’s partner’s status
facilitates disclosure [54].
Now that HIV testing is being scaled up in Burkina
Faso, Kenya, Malawi and Uganda, better integration of
PMTCT with other modes of testing, such as home-
based or workplace HTC, should be possible. The Ugan-
dan MATCH country study found home-based testing to
facilitate disclosure [55-58]. If accompanied by good fol-
low-up medical care, home-based testing enables early
treatment for both men and women, allowing them to
plan for PMTCT before pregnancy.
T h ec u r r e n ts t u d yc o n t r i b u t e st ot h ed e v e l o p m e n to f
methods to measure consent, counseling and confidenti-
ality procedures (the 3 C’s) in HIV testing. While such
studies are common in family planning [59-61], in HIV
testing the emphasis has been on measuring the accept-
ability and uptake of follow-up medical care, with rela-
tively little attention to the interpersonal processes
involved.
One limitation of the study is its purposive sampling
frame. Our sample was made up of purposively selected
antenatal care facilities in the capital city and one rural
province/district in all four countries. We aimed to
include a range of facilities in the sample to explore
diversity in HTC practice. A systematic sample of
respondents was taken in each facility, but adjustments
in the sampling procedures were made when attendance
was lower than expected. The number of ante-natal care
clients interviewed per facility varied between 5 and 30.
The samples are thus not representative of the popula-
tion of ante-natal care clients in the countries concerned.
B e c a u s eo fl o wn u m b e r so fP M T C Tr e s p o n d e n t sp e r
facility, we could not conduct multi-level analysis aimed
at analyzing the effects of country level policies, institu-
tional practices and individual factors on client satisfac-
tion with PMTCT services. Moreover, the data were
collected in 2008/2009. While this is more recent than
most published studies, the findings do not necessarily
reflect the current situation in the countries concerned.
Another limitation of the study is that the interviews
were conducted within health facilities. It is possible
that the relatively high levels of satisfaction reported in
our study were caused by desirability bias; several other
studies have shown that clients are reluctant to express
negative opinions of services when interviewed at health
facilities [62,63]. By adding open-ended questions to the
interview and by conducting additional key informant
interviews in communities, we were able to triangulate
the findings and overcome this limitation. For example,
the quantitative data suggested high levels of disclosure,
while the answers of HIV-positive pregnant women to
the open-ended questions revealed that disclosure is
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stigma and social suffering.
Finally, the relatively small number of HIV-positive indi-
viduals included in the study (N = 63) and their uneven
distribution (half are from Malawi) does not allow for
quantitative analysis of the differences in experience of
HIV-positives by country. We have therefore highlighted
our qualitative findings for this sub-population, pointing
to the common concerns of HIV-positive pregnant
women across the diverse institutional and country
settings.
Conclusion
Analysis using mixed methods is important to provide not
only measurements of perceived quality, but also insight
into women’s experiences of these services, as well as the
barriers that remain in efforts to stop transmission of HIV
from mother to child. Our study reveals that women are
generally satisfied with PMTCT services, but that there is
a lack of clarity surrounding the necessity and meaning of
consent. In Burkina Faso, the quality of counseling was
found to be sub-optimal. More in-depth studies are
needed to further elucidate the dynamics within PMTCT
to understand why, in some cases, women are not pro-
vided with good quality care.
The study further found that the majority (63%) of
HIV-positive pregnant women do not disclose their sta-
tus to partners. Some women, who did disclose, faced
rejection by their partners and/or divorce. Moreover,
20% of women experienced self-stigma, while 25%
reported that they were personally made to feel bad
because of their HIV status. These findings suggest that
the PMTCT strategy of testing pregnant women in
antenatal care–and subsequently asking them to refer
their partners–needs to be rethought. Promoting testing
options that reach men might reduce (self-)blame among
women for introducing the disease into their families and
promote disclosure. If accompanied by good follow-up
medical care, home-based testing enables early treatment
for both men and women, allowing them to plan for
PMTCT before pregnancy.
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